# Study of D-2570 in Subjects With Non-Segmental Vitiligo

> **NCT07625891** · PHASE2 · RECRUITING · sponsor: **InventisBio Co., Ltd** · enrollment: 160 (estimated)

## Conditions studied

- Vitiligo
- Non-Segmental Vitiligo (NSV)

## Interventions

- **DRUG:** D-2570 Dose 1
- **DRUG:** D-2570 Dose 2
- **DRUG:** Placebo
- **DRUG:** D-2570 Dose 3

## Key facts

- **NCT ID:** NCT07625891
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-11
- **Primary completion:** 2027-11
- **Final completion:** 2028-05
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07625891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07625891, "Study of D-2570 in Subjects With Non-Segmental Vitiligo". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07625891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*